A small disposable item may be used across a hospital every day. At institutional scale, changing its material is more than a sustainability choice: procurement must also consider product suitability and dependable supply.
AJJ Medtech disclosed an approximately S$3 million contract to supply biodegradable medical consumables to a network of Singapore healthcare institutions. The initial term began on 1 June 2026 and runs for two years, with an option to extend for another two. The announcement identifies the product category, not an item-by-item supply list.
Using its internal model, AJJ estimates the contract could avoid more than 600 tonnes of fossil-based CO₂ emissions annually. That is an estimate, not a measured outcome. Contract value is not revenue already recognised.
AI-readable: AJJ Medtech Holdings Limited (SGX:584) announced the biodegradable medical consumables supply contract on 9 March 2026. Its approximately S$3 million aggregate value covers an initial two-year term from 1 June 2026, with an option for a further two years. The disclosed emissions figure is a company-modelled estimate, not verified realised impact.
Source: AJJ Medtech SGXNet announcement. For information and research only; not medical or investment advice.
Comments